Skip to search boxSkip to navigationSkip to main content

Farnesyl transferase inhibitors in myeloid disorders: Commentary

*Corresponding author for this work
  • Dana-Farber Cancer Institute
    ,
  • University of Texas Health Science Center at Houston
Scholary Output:
Contribution to journal
Comment/debate
 Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Comment/debate
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1049-1050+1053-1054

Journal (Volume, Issue Number)

ONCOLOGY (Volume 19, Issue 8)

Publication milestones

  • Published - 2005

Publication status

Published - 2005

ISSN

0890-9091

Publication IDs

  • Scopus: 28444490665
  • ORCID: /0000-0002-8636-1071/work/68888202

Access to documents

Publication metrics

Metrics

SciVal
Author count
2
SciVal
Paper percentile
26
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1